ARS Pharmaceuticals, Inc. (SPRY) Gross profit
ARS Pharmaceuticals, Inc. (SPRY) annual gross profit history from SEC filings — each fiscal year as reported.
$89.1MFY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $89.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRY financial trends
SPRY RevenueSPRY Net incomeSPRY Net marginSPRY Gross marginSPRY Operating incomeSPRY Operating marginSPRY Operating cash flowSPRY Free cash flowSPRY Capital expendituresSPRY Return on equitySPRY Stock buybacksSPRY Dividends paidSPRY Total assetsSPRY Total liabilitiesSPRY Shareholders’ equitySPRY overview →